Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

@article{Leucht2013ComparativeEA,
  title={Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis},
  author={S. Leucht and A. Cipriani and L. Spineli and D. Mavridis and Deniz {\"O}rey and F. Richter and M. Samara and C. Barbui and R. Engel and J. Geddes and W. Kissling and M. Stapf and B. L{\"a}ssig and G. Salanti and John M. Davis},
  journal={The Lancet},
  year={2013},
  volume={382},
  pages={951-962}
}
BACKGROUND The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a hierarchy based on the randomised evidence. [...] Key Method We searched the Cochrane Schizophrenia Group's specialised register, Medline, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for reports published up to Sept 1, 2012.Expand
Lithium for schizophrenia.
Antipsychotic combinations in schizophrenia
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 60 REFERENCES
Perphenazine for schizophrenia.
...
1
2
3
4
5
...